COMMUNIQUÉS West-GlobeNewswire

New Retrospective Study Reports Significantly Reduced Post-Operative GERD Rates with the Titan SGS™ Stapler from Teleflex Compared with Multi-Fire Staplers in Sleeve Gastrectomy
13/05/2025
Data also demonstrate significantly lower rates of postoperative reflux and decreased incidence of de novo gastroesophageal reflux disease (GERD) without affecting total weight loss at 1-year*, and shorter average [...]
Arbor Biotechnologies to Present Preclinical Data for ABO-101 in PH1 at the American Society of Gene and Cell Therapy (ASGCT) 28th Annual Meeting
13/05/2025
– Data from oral presentation supported ABO-101 IND and CTA approval for clinical assessment in primary hyperoxaluria type 1 (PH1) in the Phase 1/2 redePHine study in US and UK ( NCT06839235 ) – Preclinical data [...]
NewBiologix Presents New Data at ASGCT on the Effective Manufacturing of rAAV-based therapeutics
13/05/2025
LAUSANNE, Switzerland, May 13, 2025 (GLOBE NEWSWIRE) -- NewBiologix, a next-generation biotechnology company pioneering the future of recombinant adeno-associated virus (rAAV) production through a unique DNA-based [...]
Fennec Pharmaceuticals Reports First Quarter 2025 Financial Results and Provides Business Update
13/05/2025
~ Achieved First Quarter 2025 Total Net Revenues of $8.8 Million, Up 18% Year Over Year ~ ~ Positive Momentum from Company’s Refined, Targeted Sales Strategy and Enhanced Patient Support Services ~ ~ PEDMARQSI Now [...]
The Ensign Group to Present at the 2025 RBC Capital Markets Global Healthcare Conference
13/05/2025
SAN JUAN CAPISTRANO, Calif., May 13, 2025 (GLOBE NEWSWIRE) -- The Ensign Group, Inc. (Nasdaq: ENSG), the parent company of the Ensign™ group of companies, which invest in and provide skilled nursing and senior living [...]
Ring Therapeutics Presents New Data on its AnelloBricks® Manufacturing Platform at the 28th Annual American Society of Gene & Cell Therapy Conference
13/05/2025
AnelloBricks is a promising in vitro approach to producing a new class of functional viral vectors, offering dramatic advantages in manufacturing scalability and cost compared to existing vector systems Payload [...]
Transactions of Managers and Closely Associated Persons
13/05/2025
Attached is a copy of a filing with the Luxembourg Commission de Surveillance du Secteur Financier (CSSF) regarding transactions of managers and closely associated persons, announcing the acquisition of 210,000 shares [...]
RevoluGen and ProteoQuest Join Forces to Bring Fire Monkey HMW-DNA Extraction to China and Asia Pacific’s Fast Growing DNA Sequencing-based Genomics Markets
13/05/2025
HADFIELD, United Kingdom and HONG KONG, May 13, 2025 (GLOBE NEWSWIRE) -- UK genomics tools company, RevoluGen Limited and Hong Kong-based life sciences distributor ProteoQuest Technology Co. Ltd are pleased to announce [...]
EnteroBiotix Presents Positive Data in Liver Cirrhosis at EASL 2025
13/05/2025
EnteroBiotix Presents Positive Data in Liver Cirrhosis at EASL 2025 EBX-102 was well tolerated and showed multiple positive trends over placebo Findings support progression to a Phase 2b trial Glasgow, Scotland – 13 May [...]
TILT Biotherapeutics Announces Closing of USD 25 Million Series B Financing
13/05/2025
Initiates Phase 2 platinum-resistant ovarian cancer trial HELSINKI, May 13, 2025 (GLOBE NEWSWIRE) -- TILT Biotherapeutics (Tiltbio), a clinical-stage biotechnology company developing intravenously delivered cancer [...]
Eleva Appoints Donato Spota as Chief Financial Officer
13/05/2025
Freiburg im Breisgau, Germany, May 13, 2025 – Eleva, a pioneer in discovering and developing previously inaccessible biologics based on a breakthrough technology platform, appointed Mr. Donato Spota as Chief Financial [...]
First patients dosed in final cohort of Phase 1b clinical trial of HER-096 for Parkinson’s disease
13/05/2025
Herantis Pharma Plc – Press release First patients dosed in final cohort of Phase 1b clinical trial of HER-096 for Parkinson’s disease HER-096 is a first-in-class agent in development for the treatment of Parkinson’s [...]
Galapagos Announces Strategic Update on Proposed Separation, Executive Leadership Transition and Board Changes
13/05/2025
Galapagos to re-evaluate the implementation of the previously announced separation following regulatory and market developments Galapagos to explore all strategic alternatives for its existing businesses, including cell [...]
Vivoryon Therapeutics N.V. to Hold its 2025 Annual General Meeting on June 24, 2025
13/05/2025
Vivoryon Therapeutics N.V. to Hold its 2025 Annual General Meeting on June 24, 2025 Halle (Saale) / Munich, Germany, May 13, 2025 - Vivoryon Therapeutics N.V. (Euronext Amsterdam: VVY; NL00150002Q7) ( Vivoryon ), a [...]
Ten-year APHINITY data show Roche’s Perjeta-based regimen reduced the risk of death by 17% in people with HER2-positive early-stage breast cancer
13/05/2025
Long term follow-up in this curative setting demonstrated clinically meaningful survival benefit when adding adjuvant Perjeta® (pertuzumab) to Herceptin® (trastuzumab) and chemotherapy 1 21% reduction in the risk of [...]
Kuros Biosciences to share latest MagnetOs™ market impact and strategic priorities at Capital Market Day in Zürich
13/05/2025
Kuros Biosciences to share latest MagnetOs™ market impact and strategic priorities at Capital Markets Day in Zürich Schlieren (Zürich), Switzerland, May 13, 2025 – Kuros Biosciences (“Kuros” or the “Company”) a leader [...]
IBA launches CASSY®, a new compact radiochemistry module to enhance efficiency in radiopharmaceuticals production
13/05/2025
Louvain-La-Neuve, Belgium, 13 May 2025 - IBA (Ion Beam Applications S.A., EURONEXT), the world leader in particle accelerator technology and the leading provider of radiopharmaceutical production solutions, today [...]
IBA lance CASSY®, un nouveau module compact de radiochimie pour améliorer l'efficacité de la production de radiopharmaceutiques
13/05/2025
Louvain-la-Neuve, Belgique, le 13 mai 2025 – IBA (Ion Beam Applications S.A., EURONEXT), le leader mondial des technologies d’accélération de particules et le principal fournisseur de solutions de production de [...]
NMD Pharma to present compelling preclinical data highlighting the potential of ClC-1 ion channel inhibition to improve disease symptoms and progression in MuSK myasthenia gravis at the MGFA International Conference on Myasthenia and Relate
13/05/2025
NMD Pharma to present compelling preclinical data highlighting the potential of ClC-1 ion channel inhibition to improve disease symptoms and progression in MuSK myasthenia gravis at the MGFA International Conference on [...]

Pages